Sonoma Pharmaceuticals Stock Price History
| SNOA Stock | USD 3.48 0.14 3.87% |
Below is the normalized historical share price chart for Sonoma Pharmaceuticals extending back to January 25, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sonoma Pharmaceuticals stands at 3.48, as last reported on the 21st of March, with the highest price reaching 3.62 and the lowest price hitting 3.30 during the day.
If you're considering investing in Sonoma Stock, it is important to understand the factors that can impact its price. Sonoma Pharmaceuticals appears to be unstable, given 3 months investment horizon. Sonoma Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1 % return per unit of risk over the last 3 months. By inspecting Sonoma Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.74% is justified by implied risk. Please review Sonoma Pharmaceuticals' Risk Adjusted Performance of 0.0878, coefficient of variation of 1121.78, and Semi Deviation of 4.06 to confirm if our risk estimates are consistent with your expectations.
At present, Sonoma Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 1.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 15.3 M. . At present, Sonoma Pharmaceuticals' Price Book Value Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.43, whereas Price To Sales Ratio is forecasted to decline to 0.24. Sonoma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of January 2007 | 200 Day MA 3.6085 | 50 Day MA 2.6746 | Beta 1.559 |
Sonoma |
Sharpe Ratio = 0.1002
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SNOA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.42 actual daily | 66 66% of assets are less volatile |
Expected Return
| 0.74 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Sonoma Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sonoma Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.201 | Enterprise Value Ebitda (0.17) | Price Sales 0.4186 | Shares Float 1.6 M | Wall Street Target Price 17 |
Sonoma Pharmaceuticals Stock Price History Chart
There are several ways to analyze Sonoma Stock price data. The simplest method is using a basic Sonoma candlestick price chart, which shows Sonoma Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 17, 2025 | 3.86 |
| Lowest Price | March 7, 2025 | 1.99 |
Sonoma Pharmaceuticals March 21, 2025 Stock Price Synopsis
Various analyses of Sonoma Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sonoma Stock. It can be used to describe the percentage change in the price of Sonoma Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sonoma Stock.| Sonoma Pharmaceuticals Price Daily Balance Of Power | (0.44) | |
| Sonoma Pharmaceuticals Accumulation Distribution | 10,392 | |
| Sonoma Pharmaceuticals Price Action Indicator | (0.05) | |
| Sonoma Pharmaceuticals Price Rate Of Daily Change | 0.96 |
Sonoma Pharmaceuticals March 21, 2025 Stock Price Analysis
Sonoma Stock Price History Data
The price series of Sonoma Pharmaceuticals for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.87 with a coefficient of variation of 13.2. The price distribution for the period has arithmetic mean of 2.67. The median price for the last 90 days is 2.65. The company completed stock split (1:20) on 30th of August 2024. Sonoma Pharmaceuticals had dividends distributed to its stock-holders on 2019-06-20.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 3.52 | 3.62 | 3.30 | 3.48 | 117,559 | |
| 03/20/2025 | 3.35 | 3.65 | 3.35 | 3.62 | 107,056 | |
| 03/19/2025 | 3.34 | 3.62 | 3.22 | 3.43 | 120,581 | |
| 03/18/2025 | 3.70 | 3.75 | 3.21 | 3.25 | 277,144 | |
| 03/17/2025 | 3.97 | 4.08 | 3.76 | 3.86 | 664,328 | |
| 03/14/2025 | 3.00 | 3.75 | 3.00 | 3.53 | 385,846 | |
| 03/13/2025 | 3.53 | 3.53 | 2.82 | 3.08 | 352,028 | |
| 03/12/2025 | 3.23 | 3.60 | 3.05 | 3.51 | 992,652 | |
| 03/11/2025 | 4.31 | 4.46 | 3.10 | 3.40 | 51,843,640 | |
| 03/10/2025 | 2.35 | 3.53 | 2.33 | 2.79 | 37,586,748 | |
| 03/07/2025 | 2.12 | 2.17 | 1.90 | 1.99 | 38,194 | |
| 03/06/2025 | 2.27 | 2.27 | 2.14 | 2.14 | 14,210 | |
| 03/05/2025 | 2.09 | 2.25 | 2.05 | 2.13 | 15,280 | |
| 03/04/2025 | 2.02 | 2.14 | 2.02 | 2.11 | 17,017 | |
| 03/03/2025 | 2.31 | 2.31 | 2.11 | 2.12 | 24,061 | |
| 02/28/2025 | 2.21 | 2.35 | 2.15 | 2.27 | 25,438 | |
| 02/27/2025 | 2.40 | 2.40 | 2.20 | 2.20 | 27,179 | |
| 02/26/2025 | 2.38 | 2.42 | 2.30 | 2.37 | 25,094 | |
| 02/25/2025 | 2.41 | 2.41 | 2.33 | 2.38 | 13,345 | |
| 02/24/2025 | 2.40 | 2.48 | 2.37 | 2.38 | 15,349 | |
| 02/21/2025 | 2.42 | 2.47 | 2.32 | 2.40 | 39,279 | |
| 02/20/2025 | 2.45 | 2.47 | 2.30 | 2.42 | 29,493 | |
| 02/19/2025 | 2.48 | 2.49 | 2.42 | 2.47 | 25,748 | |
| 02/18/2025 | 2.44 | 2.62 | 2.44 | 2.50 | 13,385 | |
| 02/14/2025 | 2.58 | 2.60 | 2.45 | 2.49 | 37,864 | |
| 02/13/2025 | 2.54 | 2.62 | 2.45 | 2.62 | 36,512 | |
| 02/12/2025 | 2.55 | 2.62 | 2.53 | 2.54 | 17,886 | |
| 02/11/2025 | 2.60 | 2.61 | 2.54 | 2.58 | 21,875 | |
| 02/10/2025 | 2.66 | 2.67 | 2.61 | 2.61 | 14,438 | |
| 02/07/2025 | 2.62 | 2.66 | 2.60 | 2.66 | 18,184 | |
| 02/06/2025 | 2.66 | 2.69 | 2.59 | 2.65 | 30,186 | |
| 02/05/2025 | 2.69 | 2.69 | 2.61 | 2.66 | 19,306 | |
| 02/04/2025 | 2.58 | 2.74 | 2.57 | 2.69 | 35,839 | |
| 02/03/2025 | 2.68 | 2.68 | 2.53 | 2.58 | 52,478 | |
| 01/31/2025 | 2.85 | 2.85 | 2.63 | 2.69 | 134,623 | |
| 01/30/2025 | 2.84 | 2.85 | 2.59 | 2.66 | 160,469 | |
| 01/29/2025 | 2.74 | 2.74 | 2.66 | 2.69 | 11,647 | |
| 01/28/2025 | 2.66 | 2.78 | 2.64 | 2.74 | 26,281 | |
| 01/27/2025 | 2.84 | 2.90 | 2.64 | 2.64 | 57,428 | |
| 01/24/2025 | 2.63 | 3.04 | 2.63 | 2.84 | 275,776 | |
| 01/23/2025 | 2.69 | 2.69 | 2.61 | 2.64 | 11,518 | |
| 01/22/2025 | 2.64 | 2.66 | 2.54 | 2.60 | 38,927 | |
| 01/21/2025 | 2.62 | 2.70 | 2.61 | 2.65 | 33,587 | |
| 01/17/2025 | 2.62 | 2.75 | 2.61 | 2.65 | 28,110 | |
| 01/16/2025 | 2.52 | 2.74 | 2.52 | 2.66 | 53,759 | |
| 01/15/2025 | 2.66 | 2.73 | 2.60 | 2.62 | 32,108 | |
| 01/14/2025 | 2.63 | 2.69 | 2.59 | 2.64 | 18,751 | |
| 01/13/2025 | 2.57 | 2.67 | 2.52 | 2.58 | 35,486 | |
| 01/10/2025 | 2.60 | 2.66 | 2.54 | 2.60 | 35,369 | |
| 01/08/2025 | 2.73 | 2.76 | 2.61 | 2.66 | 47,504 | |
| 01/07/2025 | 2.69 | 2.80 | 2.69 | 2.74 | 37,450 | |
| 01/06/2025 | 2.66 | 2.76 | 2.63 | 2.69 | 56,370 | |
| 01/03/2025 | 2.68 | 2.75 | 2.64 | 2.64 | 60,502 | |
| 01/02/2025 | 2.71 | 2.75 | 2.65 | 2.68 | 53,472 | |
| 12/31/2024 | 2.79 | 2.85 | 2.66 | 2.69 | 63,293 | |
| 12/30/2024 | 2.71 | 2.79 | 2.67 | 2.75 | 39,256 | |
| 12/27/2024 | 2.73 | 2.77 | 2.68 | 2.75 | 39,193 | |
| 12/26/2024 | 2.68 | 2.79 | 2.66 | 2.75 | 31,454 | |
| 12/24/2024 | 2.69 | 2.74 | 2.68 | 2.73 | 19,831 | |
| 12/23/2024 | 2.60 | 2.77 | 2.56 | 2.68 | 38,642 | |
| 12/20/2024 | 2.54 | 2.71 | 2.54 | 2.63 | 50,272 |
About Sonoma Pharmaceuticals Stock history
Sonoma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sonoma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sonoma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sonoma Pharmaceuticals stock prices may prove useful in developing a viable investing in Sonoma Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1 M | 1.1 M | |
| Net Loss | -4.6 M | -4.9 M |
Sonoma Pharmaceuticals Quarterly Net Working Capital |
|
Sonoma Pharmaceuticals Stock Technical Analysis
Sonoma Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Sonoma Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sonoma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Sonoma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sonoma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0878 | |||
| Jensen Alpha | 0.6025 | |||
| Total Risk Alpha | 1.2 | |||
| Sortino Ratio | 0.151 | |||
| Treynor Ratio | (2.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sonoma Stock analysis
When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |